All Access Articles |
- CG Oncology Reports Q3 Financial Results | 2025-11-14 | BIOTECHNOLOGY
- CG Oncology's Cretostimogene Achieves 41.8% 24-Month CR Rate | 2025-09-05 | PHARMACEUTICAL
Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!